Auriga USA

Auriga has downgraded Myriad Genetics (NASDAQ: MYGN) from Buy to Hold and has lowered the price target from $27 to $25.

Auriga USA has lowered the price target on NetLogic Microsystems (NASDAQ: NETL) from $49 to $36 and maintains its Hold rating.

Auriga USA has lowered the price target on Juniper Networks (NYSE: JNPR) from $50 to $40 and maintains its Buy rating.

Auriga USA has lowered its price target on Hanwha SolarOne (NASDAQ: HSOL) from $11 to $10 and maintains its Buy rating.

Auriga is maintaining its Buy rating and its $25 price target on Spansion Inc. (NYSE: CODE) after a strong and steady quarter. In the report, Auriga writes, “We maintain our Buy rating and $25 price target on Spansion (CODE) following a solid earnings report. Management provided detailed and...

Auriga is maintaining its Sell rating and $13 price target on SunPower Corp. (NASDAQ: SPWRA) based on a newly formed partnership with Total S.A. (NYSE: TOT). Says Auriga, “We maintain our Sell rating and $13 target on shares of SunPower (SPWRA) after the Total (TOT, NR) tender offer was announced...

Auriga has raised its price target on Cavium Networks (NASDAQ: CAVM) from $54 to $56 and are maintaining a Buy rating on the stock, following a strong quarter. Says Auriga, “We maintain our Buy rating and increase our price target to $56 from $54 as CAVM reported yet another beat and raise quarter...

Auriga has lowered its price target on ReneSola Lts. (NYSE: SOL) from $23 to $15 based on and in-line quarter, but one that fell below EPS estimate forecasts. Says Auriga, in its report, “We reduce our target to $15 from $23 after a good report but mixed management commentary. The discussion of...

Auriga has assumed coverage of United Therapeutics Corp. (NASDAQ: UTHR) at a Buy rating and with a price target of $90. According to Auriga, “We are assuming coverage of United Therapeutics (UTHR) with a Buy rating and a $90 price target. UTHR reported 1Q11 revenues that were once again below both...

Auriga USA has upgraded Illumina Inc. (NASDAQ: ILMN) from Neutral to Buy and reiterates its $75 price target.

Auriga USA has published a research report on NetEase.com (NASDAQ: NTES) after the company reported its strength due to game sales and benefits from China's growing economy. In the report, Auriga writes "NTES has a good line up of high quality games, which makes 2011 an exciting year for the...

Today, Auriga USA announced that it has downgraded shares of Thoratec Corporation (NASDAQ: THOR) from Buy to Hold. Auriga USA has also lowered its price target from $85 to $29. Thoratec Corporation currently trades at $31.67.

Auriga USA announced today that it has initiated coverage on STR Holdings, Inc. (NYSE: STRI) with a Hold rating and $25 price target. STR Holdings currently trades at $24.93.

Auriga USA has downgraded Solarfun Power (NASDAQ: SOLF) from Buy To Hold with a $13 price target.

Auriga USA has reiterated its Buy ratings on the following companies: MetroPCS (NYSE: PCS) price target raised from $11 to $13 Omnicell (NASDAQ: OMCL) price target raised from $15 to $16